Showing posts with label gel. Show all posts
Showing posts with label gel. Show all posts

Monday, 17 April 2023

Development of Ethosomal Gel Loaded with Terminalia chebula for Effective Treatment of Arthritis | Chapter 7 | Current Overview on Pharmaceutical Science Vol. 9

 Oral route is ultimate common route of drug delivery, that has many advantages to a degree easy delivery, but further has disadvantages to a degree poor bioavailability, a tendency to produce rapid ancestry level spikes, necessitating taller doses or recurrent drug, which is difficult for the patient, and extreme cost. With all of these disadvantages in mind, skilled is a need for novel drug delivery with enhanced therapeutic efficacy and security through targeted transmittal, so that the size and number of doses maybe diminished. This maybe accomplished through transdermal delivery, that has several benefits such as avoiding first pass absorption, eliminating GI sensitivity, reducing frequency of drug, and terminating drug action quickly, etc. The familiar property of ethosomes that is to say its faster rate of drug delivery create it a suitable choice for intend drug delivery formulations for several types of never-ending inflammatory disorders place rationale of therapy turns deadly on longer course of maintenance or during relapse of the illness. To underrate the toxicity or sub-healing effect of Terminalia chebula and conversely to potentiate its engaged use in arthritis, transdermal formulation with ethosomes ability contribute a importance in its therapeutic security.Dried fruits of Terminalia chebula was culled and preliminary phytochemical evaluation was performed. Soya lecithin was used to make ethosome using a cold design.  Ethosomal gel was prepared by utilizing carbopol as gelling agent and was judged.The pharmaceutical properties of the arranged gel were judged and found to be acceptable. In comparison to the gel with extract, the invitro drug spread of ethosomal gel demonstrated better release. Invitro anti-arthritic exercise was significantly above that of standard diclofenac.In light of the aforementioned considerations, the aim of the current study was to forge a natural drug-loaded ethosomal coagulate for transdermal drug delivery, improving drug permeation compared to unoriginal dosage forms.

Author(s) Details:

Saranya Balasubramaniyam,
College of Pharmacy, Saveetha Institute of Medical and Technical Sciences, Thandalam, Kanchipuram, Chennai, Tamil Nadu-602105, India.

X. Fatima Grace,
Department of Pharmaceutics, Faculty of Pharmacy, Dr. MGR Educational and Research Institute (DU), Velappanchavadi, Chennai – 600 077, India.

Please see the link here: https://stm.bookpi.org/COPS-V9/article/view/10172


Saturday, 17 September 2022

A Brief Review on Cross-linking in Hydrogel| Chapter 3 | Research Aspects in Chemical and Materials Sciences Vol. 3

 In polymer science, cross-connecting is a settling technique that outcomes in the complex expansion of the polymeric chain and organization structure. A cross-interface is a bond that associates two polymer chains. It very well may be covalent or ionic. By restricting development, cross connecting transforms a fluid polymer into a "strong" or "gel." Polymer chains lose a portion of their ability to move freely when they are associated by cross-joins. Hydrogels are a sort of polymer with a high water content that has physical or synthetic crosslinks. By cross-connecting the chains, a fluid polymer (where the chains are allowed to stream) can be changed into a "strong" or "gel." A polymer with cross connecting has a bigger sub-atomic mass. Since they are precisely hearty and impervious to intensity, wear, and dissolvable assault, cross-connected polymers are critical. Cross-connected polymers have the detriment of being insoluble and infusible, which makes them somewhat unbending with regards to handling qualities.


Author(s) Details:

Jaya Maitra,
Gautam Buddha University, Greater Noida, Gautam Budh Nagar – 201312, (U.P.), India.


Please see the link here: https://stm.bookpi.org/RACMS-V3/article/view/8231